Quercetin Alleviates Chronic Urticaria by Negatively Regulating IgE‐Mediated Mast Cell Activation Through CD300f

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Chenrui Zhao, Na Wang, Chao Wang, Yujuan Yuan, Hongfen Du, Yuanyuan Ding, Hongli An
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867011797255454720
author Chenrui Zhao
Na Wang
Chao Wang
Yujuan Yuan
Hongfen Du
Yuanyuan Ding
Hongli An
author_facet Chenrui Zhao
Na Wang
Chao Wang
Yujuan Yuan
Hongfen Du
Yuanyuan Ding
Hongli An
Chenrui Zhao
Na Wang
Chao Wang
Yujuan Yuan
Hongfen Du
Yuanyuan Ding
Hongli An
collection Wiley Open Access
contents Quercetin Alleviates Chronic Urticaria by Negatively Regulating IgE‐Mediated Mast Cell Activation Through CD300f Chenrui Zhao Na Wang Chao Wang Yujuan Yuan Hongfen Du Yuanyuan Ding Hongli An Phytotherapy Research ABSTRACTChronic urticaria (CU) is a skin allergy caused by the excessive activation of mast cells. The main etiology of CU is a type I allergic reaction mediated by immunoglobulin (Ig)E. This study mainly explored the therapeutic effect of quercetin in ovalbumin (OVA)‐induced CU mice and investigated its target and mechanism in vitro. The CU symptom‐alleviating effect of quercetin was assessed by the CU model. The possible molecular mechanisms of quercetin were initially inferred through bioinformatic and multi‐database analyses. Quercetin targets were examined using mast cell activation experiments with CD300f knockdown. RT‐PCR and western blot experiments were performed to verify the molecular mechanisms of quercetin. Quercetin relieved wheal and scratching times on the back skin of mice as well as reduced eosinophilic infiltration and mast cell degranulation in the skin lesions and inhibited the release of IgE, histamine, TNF‐α, MCP‐1, and IL‐13 in the serum of mice. In addition, it exhibited potential therapeutic effects on CU through the PI3K‐Akt signaling pathway. Meanwhile, quercetin upregulated CD300f in the skin of CU, activated CD300f, and induced downstream SHP‐1 phosphorylation. Of note, quercetin bound to CD300f to prevent IgE‐mediated LAD2 cell β‐hexosaminidase release, histamine release, Ca2+ influx, mast cell degranulation, and F‐actin cytoskeleton remodeling by inhibiting the AKT/IKK/NF‐κB inflammatory pathway. The study results suggest that quercetin alleviates CU by activating the CD300f/SHP‐1 signaling pathway. In addition, it activates CD300f to inhibit IgE‐mediated mast cell degranulation and F‐actin cytoskeleton remodeling by inhibiting the AKT/IKK/NF‐κB inflammatory pathway. 10.1002/ptr.8516 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8516
format Artículo Open Access
id wiley_oa_10_1002_ptr_8516
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Quercetin Alleviates Chronic Urticaria by Negatively Regulating IgE‐Mediated Mast Cell Activation Through CD300f
Chenrui Zhao
Na Wang
Chao Wang
Yujuan Yuan
Hongfen Du
Yuanyuan Ding
Hongli An
Phytotherapy Research
Quercetin Alleviates Chronic Urticaria by Negatively Regulating IgE‐Mediated Mast Cell Activation Through CD300f Chenrui Zhao Na Wang Chao Wang Yujuan Yuan Hongfen Du Yuanyuan Ding Hongli An Phytotherapy Research ABSTRACTChronic urticaria (CU) is a skin allergy caused by the excessive activation of mast cells. The main etiology of CU is a type I allergic reaction mediated by immunoglobulin (Ig)E. This study mainly explored the therapeutic effect of quercetin in ovalbumin (OVA)‐induced CU mice and investigated its target and mechanism in vitro. The CU symptom‐alleviating effect of quercetin was assessed by the CU model. The possible molecular mechanisms of quercetin were initially inferred through bioinformatic and multi‐database analyses. Quercetin targets were examined using mast cell activation experiments with CD300f knockdown. RT‐PCR and western blot experiments were performed to verify the molecular mechanisms of quercetin. Quercetin relieved wheal and scratching times on the back skin of mice as well as reduced eosinophilic infiltration and mast cell degranulation in the skin lesions and inhibited the release of IgE, histamine, TNF‐α, MCP‐1, and IL‐13 in the serum of mice. In addition, it exhibited potential therapeutic effects on CU through the PI3K‐Akt signaling pathway. Meanwhile, quercetin upregulated CD300f in the skin of CU, activated CD300f, and induced downstream SHP‐1 phosphorylation. Of note, quercetin bound to CD300f to prevent IgE‐mediated LAD2 cell β‐hexosaminidase release, histamine release, Ca2+ influx, mast cell degranulation, and F‐actin cytoskeleton remodeling by inhibiting the AKT/IKK/NF‐κB inflammatory pathway. The study results suggest that quercetin alleviates CU by activating the CD300f/SHP‐1 signaling pathway. In addition, it activates CD300f to inhibit IgE‐mediated mast cell degranulation and F‐actin cytoskeleton remodeling by inhibiting the AKT/IKK/NF‐κB inflammatory pathway. 10.1002/ptr.8516 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Quercetin Alleviates Chronic Urticaria by Negatively Regulating IgE‐Mediated Mast Cell Activation Through CD300f
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8516